ESTIMATED
03/14/2024
03/14/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$6.00 | -$6.00 | -$6.00 |
Q2 2024 | 2 | -$4.00 | -$3.00 | -$3.50 |
Q3 2024 | 0 | -$3.00 | -$3.00 | -$3.00 |
Q4 2024 | 0 | -$3.00 | -$3.00 | -$3.00 |
Q1 2025 | 1 | -$3.00 | -$3.00 | -$3.00 |
Q2 2025 | 1 | -$2.00 | -$2.00 | -$2.00 |
Q3 2025 | 1 | -$1.00 | -$1.00 | -$1.00 |
Q4 2025 | 1 | -$1.00 | -$1.00 | -$1.00 |
Q1 2026 | 0 | $0.00 | $0.00 | $0.00 |
Q2 2026 | 0 | $1.00 | $1.00 | $1.00 |
Heart Test Laboratories, Inc. last posted its earnings results on Thursday, March 14th, 2024. The company reported $-3 earnings per share for the quarter, missing analysts' consensus estimates of $-0.06 by $2.94. The company had revenue of 14,700 for the quarter and had revenue of 5,150 for the year. Heart Test Laboratories, Inc. has generated $-62 earnings per share over the last year ($-61.74 diluted earnings per share) and currently has a price-to-earnings ratio of -39.77. Heart Test Laboratories, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 17th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 03/14/2024 | Q3 2024 | -$0.06 | -$0.03 | 0.03 | $14,700 | $14,700 | 12/14/2023 | Q2 2024 | -$0.12 | -$0.16 | -0.04 | $3,900 | 09/14/2023 | Q1 2024 | -$0.14 | -$0.13 | 0.01 | $0 | 07/18/2023 | Q4 2023 | -$0.16 | $5.14 M | 03/16/2023 | Q3 2023 | $0.16 | -$0.16 | -0.32 | $1,000 | $1,950 | 12/15/2022 | Q2 2023 | -$0.33 | -$0.22 | 0.11 | $0 | 09/12/2022 | Q1 2023 | -$0.31 | $3,200 | 07/29/2022 | Q4 2022 | -$0.64 | $4,149 | 01/31/2022 | Q3 2022 | -$0.15 | $2,740 | 10/30/2021 | Q2 2022 | -$0.13 | $0 | 07/30/2021 | Q1 2022 | -$0.06 | $7,484 | 04/29/2021 | Q4 2021 | -$0.11 | $14,950 |
---|
A. Heart Test Laboratories, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 17th, 2024 based off last year's report dates.
A. The conference call for Heart Test Laboratories, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Heart Test Laboratories, Inc.'s latest earnings report can be read online.
A. Heart Test Laboratories, Inc. (NASDAQ:HSCS) has a recorded annual revenue of $5,150.
A. Heart Test Laboratories, Inc. (NASDAQ:HSCS) has a recorded net income of $5,150. Heart Test Laboratories, Inc. has generated $-61.74 earnings per share over the last four quarters.
A. Heart Test Laboratories, Inc. (NASDAQ:HSCS) has a price-to-earnings ratio of -39.77 and price/earnings-to-growth ratio is 0.